Bayer Aktiengesellschaft

Elanco Animal Health Gmbh

Bayer Intellectual Property Gmbh

Bayer Animal Health Gmbh

Stefan Hofmann

Heiko Herold

Venkata-Rangarao Kanikanti

Stefan Schillberg

Hans-Juergen Hamann

Hans-Christian Mundt

Frank Behrendt

Maya Vinzing

Kirsten Borngen

Andre Fellholter

Barbara Schulte

Helga Schinkel

Sandra Mangold-gehring

Brigitte Pommer

Annette BÖGEL

Franziska Schmidt

Juan Agustin Torres Islas

Stefan Vogel

The present invention relates to a formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies containing a triazinone such as toltrazuril and a polynuclear iron(III) polysaccharide complex compound together with a specifically selected surfactant that has a hydrophilic-lipophilic-balance (HLB) value of ≥10.

Formulation for the use in the simultaneous treatment of coccidial infections and iron deficiencies

The process for producing crystallisation products with an average particle diameter of &lt;1 .mu.m is based on the atomisation of a solution and the simultaneous evaporation of the solvent. The atomised solution A crystallises in a gas atmosphere, in which it is simultaneously contacted with a cloud of drops 4 of a surfactant-containing liquid B, thus forming an aerosol mixture A, B which is then deposited in the form of a colloidal crystal suspension in which the surfactant-containing liquid B forms the continuous phase. The cloud of drops 4 of the surfactant-containing liquid can also be produced by atomisation.

Process for producing ultrafine-crystallization products

Growing community of inventors

Langenfeld, Germany

Stefan Hofmann